InfectoGnostics

News

Limit by date

Page 1 of 7.

InfectoGnostics signs the Diversity Charter

The Diversity Charter promotes the recognition, appreciation, and inclusion of diversity in the world of work.

Read more

Multi-Million Investment in Thuringian Startups: Three InfectoGnostics Partners Secure Funding Rounds

applyo Jena, DeepEn, and Fluidect – three dynamic startups from the InfectoGnostics Research Campus Jena have successfully closed funding rounds to further develop their technologies and accelerate market entry. These companies exemplify the successful transfer of cutting-edge research into…

Read more

SESSION "TECHNOLOGY CORNER IN DIAGNOSTICS" AT AMR-CONFERENCE 2025 IN BASEL

The upcoming AMR Conference will feature a pivotal session moderated by Jens Hellwage (InfectoGnostics Research Campus Jena) and supported by the Thuringian Cluster Management.

Read more

Anonymization for secure data use - AVATAR contributions to AnoSiDat congress in Lübeck

About 200 participants, including researchers, guests and interested members of the public, came together at media docs in Lübeck from 16 to 17 April to discuss the anonymization of personal data

Read more

InfectoGnostics and partners at the German Biotechnology Days 2024 in Berlin

At the DBT 2024, the InfectoGnostics research campus once again presented Thuringian technologies and products for the fields of biotechnology, diagnostics and medical technology.

Read more

Strategy meeting of the Council of the German BioRegions

Analysis and strategic realignment at the meeting in Cologne

Read more

Consistently positive response at the joint Thuringian diagnostics stand at MEDICA 2023

The two Thuringian innovation clusters Medways and InfectoGnostics organized a joint stand for the first time in the Diagnostics Hall 3

Read more

Austausch zwischen LifeScience-Experten aus Norditalien mit der Landesentwicklungsgesellschaft Thüringen und dem Forschungscampus InfectoGnostics in Modena und Mailand.

Thuringia's life sciences sector intensifies international cooperation in northern Italy

From October 2 to 5, 2023, the State Development Agency of Thuringia (LEG) together with the InfectoGnostics Research Campus presented the Thuringian life sciences sector during a trip to Italy. The trip was supported by Germany Trade and Invest (GTAI) and organized by the Italian Chamber of…

Read more

[Translate to English:] Das Gyntect-Testkit der Firma oncgnostics: Mit dem epigenetischen Test lassen sich Krebsvorstufen früh erkennen.

Hong-Kong Firm invests in Jena-Based Ongnostics GmbH

The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a multi-million Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics – an InfectoGnostics partner – has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. The goal now is…

Read more

Visitors at the Blink AG booth at the AACC & Clinical Lab Expo 2023 in Anaheim, CA, USA

"Blink One" presentation at AACC: Campus partner BLINK DX introduces open diagnostics platform in the U.S.

InfectoGnostics partner BLINK DX presented its new "Blink One" diagnostic platform in Anaheim, California, at the annual meeting of the American Association for Clinical Chemistry (AACC). The new platform enables very fast digital PCR (dPCR) in a few minutes without microfluidics and allows the…

Read more

Page 1 of 7.